Anita Burrell

VP, Teriflunomide/MS Unit Head

Sanofi

Teresa DeLuca

Vice President-Pharmacy Health Solutions

Humana

Lida Etemad

PharmD, MS, VP, Pharmacy Management Strategies

United Healthcare

Marcus joined Genentech in September 1986 as its first Washington, DC based Clinical Marketing Specialist. After 8 years in this position he joined the newly formed Managed Care Department at Genentech with responsibility for all Federal programs. In January of 2002 …more ›

Marcus Farbstein

Director, 340B Program Management

Genentech

Beckie Fenrick

Former Senior Director Medical Operations Care Models

Blue Cross and Blue Shield of Florida

Dr. Chia Wen Lee Grossman is not your typical number crunching epidemiologist or statistician; she is an extremely versatile executive with significant scientific and business development experience, across various delivery systems (clinical, pharmaceutical/ biotechnolo…more ›

Chia Wen Lee Grossman

Head Emerging Markets Access

Biogen Idec

Dr Engelbert Günster studied chemistry at the University of Mainz and received a PhD in chemistry. For almost 30 years he has been working with Boehringer Ingelheim where Dr Günster has passed several, also international positions. Amongst others Dr G&…more ›

Engelbert Guenster

Country Head

Boehringer Ingelheim

Dr. Usman Iqbal MD, MPH, MBA, is the head of Oncology Global Evidence & Value Development at Sanofi, where he is responsible for developing product value for Sanofi’s oncology/hematology portfolio through strategic development, execution and translation of evidence …more ›

Usman Iqbal

Senior Director, Head of Oncology - Global Evidence & Value Development

Sanofi

Dr Jan (Saira), leads the Horizon Blue Cross Blue Shield of New Jersey pharmacy clinical management program as a Clinical Director with over 17 years of experience in health care management and research and academics. Dr Jan is responsible for managing Horizon’s pharmac…more ›

Saira A Jan

Director Clinical Pharmacy Program Management

Blue Cross Blue Shield of New Jersey

Steven Labkoff

Head, Strategic Programs, R&D Information

AstraZeneca

Michael Paas

Senior Vice President

GfK Bridgehead

Arup Pramanik

Executive Director for Market Access LatAm

Novartis

Ed Schoonveld is a Principal with ZS Associates in New York, NY and Lead for the firm’s Market Access and Pricing Practice. He has extensive experience in pharmaceutical marketing and pricing from both the corporate pharma and consultancy perspective. He has gained …more ›

Ed Schoonveld

Principal

ZS Associates Inc

Dr. Josephine Sollano is a Global Leader in Health Economics and Outcomes Research and Medical Communications Teams for Pfizer, Inc. within the Oncology Business Unit based in New York City. In her current role, Jo is responsible for the strategic development of economi…more ›

Josephine Sollano

Head, Global Health Economics and Outcomes

Pfizer

George Wyatt is the Managing Director of Wyatt Health Management which he founded in 2002 after a very successful 20-year career in the pharmaceutical industry. He held a number of senior positions in the industry, including Director, Market Access and Policy Developme…more ›

George Wyatt

President and Managing Director

Wyatt Health Management

The most comprehensive pharma market access forum in the US

Experts in market access, pricing and health policy will provide delegates with the most comprehensive review of the US health reform.

This event will examine new strategies to control drug costs and reduce budget deficits whilst widening patient access. You will hear a balanced discussion between industry and public, private sector payers.

Speak at Market Access World USA 2012 ›

Sponsor or exhibit at Market Access World USA 2012 ›

Come to Market Access World USA 2012 to learn

the impact of reimbursement models on market access
how will CER differ from the EU HTA experience
HTA agency policy and practice globally
how the US economy will impact state Medicaid programs
the impact of changing incentive structures
the importance of risk sharing, value based pricing and pay for performance
how to generate data specifically for payers in comparative effectiveness research
how to overcome the challengers in the emerging markets of Latin America & Asia

Limited opportunities to speak at the conference exist for leading solution providers

Who should attend

Health Policy
Market Access
Pricing & Reimbursement
Health Economics/Outcomes
HTA/Comparative Effectiveness
Evidence Based Medicine
Pharmacoeconomics
Chief Pharmacy Officers
Chief Medical Officers
Marketing
Medical Affairs
Government, Payer & Stakeholder relations

become a speaker ›

become a sponsor ›

World class solution providers attend to

Position their products and services in front of decision makers from major pharma and biotech companies
Meet and do business with senior execs within the pharmaceutical market access and pricing reimbursement community
Position themselves as a thought leader
Generate leads and new business

get the prospectus ›

download the post event report ›